TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

Immunity
P SchneiderJ Tschopp

Abstract

TRAIL induces apoptosis through two closely related receptors, TRAIL-R1 (DR4) and TRAIL-R2 (DR5). Here we show that TRAIL-R1 can associate with TRAIL-R2, suggesting that TRAIL may signal through heteroreceptor signaling complexes. Both TRAIL receptors bind the adaptor molecules FADD and TRADD, and both death signals are interrupted by a dominant negative form of FADD and by the FLICE-inhibitory protein FLIP. The recruitment of TRADD may explain the potent activation of NF-kappaB observed by TRAIL receptors. Thus, TRAIL receptors can signal both death and gene transcription, functions reminiscent of those of TNFR1 and TRAMP, two other members of the death receptor family.

References

Sep 10, 1993·Cell·L A TartagliaD V Goeddel
Mar 1, 1996·The Journal of Biological Chemistry·A M ChinnaiyanV M Dixit
May 31, 1996·The Journal of Biological Chemistry·R M PittiA Ashkenazi
Jun 1, 1996·Current Biology : CB·S A MarstersA Ashkenazi
Nov 28, 1996·Nature·J KitsonS N Farrow
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·J BertinJ I Cohen
Feb 7, 1997·Cell·S Nagata
Apr 4, 1997·Science·G PanV M Dixit
Jun 1, 1997·Immunity·H B ShuD V Goeddel
Jul 25, 1997·The Journal of Biological Chemistry·S M SrinivasulaE S Alnemri
Jul 25, 1997·The Journal of Biological Chemistry·P SchneiderJ Tschopp
Dec 31, 1997·FEBS Letters·P SchneiderJ Tschopp

❮ Previous
Next ❯

Citations

May 29, 1998·European Journal of Immunology·S M Mariani, P H Krammer
Apr 11, 2001·Head & Neck·B R Gastman
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W A Faubion, G J Gores
Jan 17, 2002·The Journal of Pathology·Tineke TimmerSteven de Jong
Jul 18, 2001·Pathology Oncology Research : POR·I Peták, J A Houghton
Aug 23, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Constance Assohou-LutyHarald Wajant
May 3, 2005·Cancer Immunology, Immunotherapy : CII·Thomas J Sayers, William J Murphy
Nov 5, 1998·International Journal of Clinical & Laboratory Research·M Muzio
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·V K PuduvalliA P Kyritsis
May 24, 2007·Apoptosis : an International Journal on Programmed Cell Death·Claudia Alexandra DumitruErich Gulbins
Jun 2, 2010·Apoptosis : an International Journal on Programmed Cell Death·Zhi Gang MaoXu Dong Zhang
Jan 6, 2011·Apoptosis : an International Journal on Programmed Cell Death·Hyun Ho Park
Apr 25, 2007·Breast Cancer Research and Treatment·Natalya V GusevaMichael B Cohen
Aug 31, 2012·Journal of Pharmacokinetics and Pharmacodynamics·Brittany P KayDavid Z D'Argenio
Sep 2, 2003·Gastroenterology·Hong Sug KimSug Hyung Lee
May 17, 2000·Pharmaceutica acta Helvetiae·W Froestl
May 17, 2000·Pharmaceutica acta Helvetiae·P Schneider, J Tschopp
Dec 26, 2001·Pharmacology & Therapeutics·K C ZimmermannD R Green
Sep 16, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Patrizia MariniClaus Belka
Mar 27, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Paula C Ashe, Mark D Berry
Aug 15, 2002·Cancer Letters·Yung-Ming Jeng, Hey-Chi Hsu
Apr 23, 2003·Cancer Letters·Young-Ju JangHyung-Il Kim
Mar 12, 2003·Toxicology Letters·Marion MacFarlane
Sep 21, 2000·Pathophysiology : the Official Journal of the International Society for Pathophysiology·K Kannan, S K Jain
Oct 31, 1998·Current Opinion in Immunology·T S Griffith, D H Lynch
Mar 26, 2003·Seminars in Cancer Biology·Nesrin Ozören, Wafik S El-Deiry
Dec 19, 2002·Cytokine & Growth Factor Reviews·Tudor M Baetu, John Hiscott
Jun 24, 1999·Cytokine & Growth Factor Reviews·H WajantP Scheurich
Feb 24, 2001·Breast Cancer Research and Treatment·M M KeaneS Lipkowitz
Mar 22, 2002·Nature Reviews. Immunology·M Thome, J Tschopp
Dec 14, 2011·Cell Death and Differentiation·J Silke, J E Vince

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis